Liver cirrhosis is associated with a lower immune response to COVID-19 vaccines but not with reduced vaccine efficacy

The overall responsiveness of patients with chronic liver disease (CLD) to COVID-19 vaccines has been shown to be decreased in patients with cirrhosis. A new prospective study in JHEP Reports shows that this lower response is observed up to six months following two-dose COVID-19 mRNA vaccination, but it does not reduce vaccine efficacy.

Leave A Comment

Your email address will not be published. Required fields are marked *